EDN1 and myeloid sarcoma: They found that astrocytes in postmortem samples of cerebral white matter from individuals without neurological disease did not visually show ET-1 immunostaining, whereas reactive astrocytes in demyelinated plaques form patients with secondary progressive MS were strongly positive for ET-1.